Skip to content

13F-HR filed by Camber Capital Management LP

Camber Capital Management LP filed this 13F-HR for the quarter ended 2014-09-30, filed 2014-11-14, with 37 holding rows worth $1,064,111,000.

Accession
0001546927-14-000198
Filed
2014-11-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2014

A holdings report, 37 entries on the cover page, a total value of $1,064,111,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,064,111,000 with VALUE read as thousands by filing date, 13F file number 028-13745. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS881624209ADR1,750,000$94,062,000thousands by filing date
MYLAN INC628530107COM1,400,000$63,686,000thousands by filing date
MASIMO CORP COM574795100Stock2,700,000$57,456,000thousands by filing date
GENOMIC HEALTH, INC.37244C101COM2,000,000$56,620,000thousands by filing date
GLAXOSMITHKLINE PLC-ADR37733W105SPONSORED ADR1,200,000$55,164,000thousands by filing date
VOLCANO CORPORATION928645100COM5,050,000$53,732,000thousands by filing date
CONMED CORP COM207410101Stock1,385,000$51,023,000thousands by filing date
EXPRESS SCRIPTS HLDG CO30219G108COM700,000$49,441,000thousands by filing date
KERYX BIOPHARMACEUTICALS492515101COMMON STOCK3,500,000$48,125,000thousands by filing date
GLAXOSMITHKLINE PLC-ADR37733W105SPONSORED ADR1,000,000$45,970,000thousands by filing datecall
Vertex Pharmaceuticals Incorporated92532F100COM400,000$44,924,000thousands by filing date
ORTHOFIX INTL N VN6748L102COM1,210,164$37,467,000thousands by filing date
UNIVERSAL AMERN CORP NEW91338E101COM4,178,259$33,593,000thousands by filing date
ACHILLION PHARMACEUTICALS IN00448Q201COM3,250,000$32,435,000thousands by filing date
ARIAD PHARMACEUTICALS INC04033A100COM6,000,000$32,400,000thousands by filing date
QUEST DIAGNOSTICS INC COM74834L100Stock500,000$30,340,000thousands by filing date
WEIGHT WATCHERS INTL INC948626106COM1,000,000$27,440,000thousands by filing date
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS881624209ADR500,000$26,875,000thousands by filing datecall
AMAG PHARMACEUTICALS INC00163U106COM750,000$23,932,000thousands by filing date
SEQUENOM INC COM NEW817337405COM8,000,000$23,760,000thousands by filing date
NOVAVAX INC670002104COMMON STOCK4,750,000$19,807,000thousands by filing date
BRUKER CORP116794108COM1,000,000$18,515,000thousands by filing date
ICU MED INC44930G107COM277,583$17,815,000thousands by filing date
BIO REFERENCE LABS INC09057G602COM543,724$15,257,000thousands by filing date
WELLCARE HEALTH PLANS INC94946T106COM235,174$14,190,000thousands by filing date
OTONOMY INC68906L105COM573,000$13,752,000thousands by filing date
AMARIN CORP PLC023111206SPONS ADR NEW12,000,000$13,080,000thousands by filing date
CROSS CTRY HEALTHCARE INC227483104COM1,000,000$9,290,000thousands by filing date
CARDICA INC14141R101COM8,374,846$8,961,000thousands by filing date
GENMARK DIAGNOSTICS INC372309104COM908,100$8,146,000thousands by filing date
PTC THERAPEUTICS INC69366J200COM158,149$6,960,000thousands by filing date
GERON CORP374163103COM3,440,045$6,880,000thousands by filing date
BIOLASE INC090911108COMMON STOCK2,715,119$6,761,000thousands by filing date
ANGIODYNAMICS INC03475V101COM364,630$5,003,000thousands by filing date
PROTALIX BIOTHERAPEUTICS INC74365A101COM2,000,000$4,840,000thousands by filing date
TARGACEPT INC87611R306COM1,560,000$3,947,000thousands by filing date
INOVIO PHARMACEUTICALS INC45773H201COM NEW250,000$2,462,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001546927-14-000198this filing2014-11-14acceptance time not in the bulk data set